drugset / Trial / NCT06386783

Fentanyl Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Spinal Anesthesia ; Peritoneal Symptomatic Effects

NCT06386783

Phase 3 Unknown 148 enrolled Aswan University
RandomizedParallel-groupTriple-blindTreatment

Summary

To compare whether 5 μg dexmedetomidine with 25 μg fentanyl added to 0.5% hyperbaric bupivacaine as adjuvants in spinal anaesthesia in patients undergoing appendectomy could reduce intraoperative peritoneal related symptoms.

Timeline

Start
2023-07-01
Primary completion
2024-07-01
Completion
2025-02-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 5 ug Intrathecal
Comparator Fentanyl Other / unclassified 25 ug Intrathecal

Indications

No indication recorded.